Brief: Bionexus Gene Lab Corp. Announces Pricing Of $5 Mln Public Offering And Uplisting To Nasdaq

Bionexus Gene Lab

20/07/2023 19:07

July 20 (Reuters) - BioNexus Gene Lab Corp:
    * BIONEXUS GENE LAB CORP. ANNOUNCES PRICING OF $5 MILLION
PUBLIC
OFFERING AND UPLISTING TO THE NASDAQ CAPITAL MARKET
    * BIONEXUS GENE LAB CORP - PRICING OF ITS PUBLIC OFFERING OF
1.3
MILLION SHARES OF COMMON STOCK AT A PRICE OF $4.00 PER SHARE
    * BIONEXUS GENE LAB - SHARES HAVE BEEN APPROVED FOR LISTING
ON
NASDAQ; EXPECTED TO COMMENCE TRADING ON JULY 20
    * BIONEXUS GENE LAB CORP - SHARES APPROVED FOR LISTING ON
NASDAQ
CAPITAL MARKET, EXPECTED TO COMMENCE TRADING ON JULY 20, 2023,
UNDER SYMBOL "BGLC"

Further company coverage:  BGLC.O 

 ((Reuters.Briefs@thomsonreuters.com;))